Antisense Therapeutics Limited
ATHJF · OTC
6/30/2024 | 12/30/2023 | 6/30/2023 | 12/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $11,867 | $17,193 | $10,967 | $16,623 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $2,509 | $2,615 | $1,659 | $1,259 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $138 | $0 | $60 |
| Total Curr. Assets | $14,473 | $19,946 | $12,692 | $17,942 |
| Property Plant & Equip (Net) | $57 | $33 | $151 | $192 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $57 | $33 | $151 | $192 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $14,530 | $19,979 | $12,843 | $18,134 |
| Liabilities | – | – | – | – |
| Payables | $3,729 | $596 | $1,023 | $936 |
| Short-Term Debt | $0 | $16 | $0 | $95 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $246 | $2,633 | $186 | $525 |
| Total Curr. Liab. | $5,152 | $3,525 | $2,812 | $1,994 |
| LT Debt | $0 | $0 | $0 | $90 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $15 | $6 | $7 | $3 |
| Total NC Liab. | $15 | $6 | $55 | $92 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $40 | $16 | $142 | $90 |
| Total Liabilities | $5,167 | $3,531 | $2,867 | $2,086 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $109,371 | $109,371 | $98,263 | $98,263 |
| Retained Earnings | -$101,730 | -$94,554 | -$92,289 | -$86,183 |
| AOCI | $1,722 | $1,632 | $4,002 | $3,967 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $9,363 | $16,448 | $9,976 | $16,047 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $14,530 | $19,979 | $12,843 | $18,134 |
| Net Debt | -$11,867 | -$17,177 | -$10,967 | -$16,438 |